Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIRCERA versus reference ESAs in chronic kidney disease-related anemia
2007-005129-31Phase 4Completed
- Sponsor
- Roche
- Start
- Aug 2008
- Modality
- Recombinant Proteins and Enzymes, Erythropoietins → Hormones & Growth Factors → Recombinant Proteins and Enzymes, Interleukins → Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of Epoetin alfa RB, darbepoetin alfa, epoetin alfa, epoetin beta in Uraemic Anaemia, sponsored by Roche. Started Aug 2008; status: completed.
02
Drugs
Epoetin alfa RBdarbepoetin alfaepoetin alfaepoetin beta
03
Conditions
Uraemic Anaemia
Beyond the preview
Go deeper on 2007-005129-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005129-31.